Business · 17/04/2012Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval for Tiamulin Animal Drug Application
Summary
The FDA is withdrawing approval of certain parts of a new animal drug application for tiamulin, a medicated article, due to its no longer being marketed for increased weight gain and improved feed efficiency in swine, at the sponsor's request.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →